Pfizer sells Esperion unit
From Times Wire Services
Pfizer Inc. sold Esperion Therapeutics Inc., a company it bought for $1.3 billion more than four years ago, to a group of venture capital firms that are investing $22.8 million in the company.
Aisling Capital, Alta Partners and Domain Associates led the financing, which Pfizer will share in return for a stake in the company. The terms of the deal weren’t disclosed.
